Page 1 | Search Results | Blood | American Society of Hematology

1-7 of 7

Sort by

Sort Order Select

Journal Articles

Enhanced Outcome Prediction in Early Stage Classical Hodgkin Lymphoma Using Pre-Treatment Biomarkers and Interim PET (BioPET); A Sub-Analysis of the UK NCRI RAPID Trial

Kim M Linton, MBChB, PhD, Joanna M Oladipo, PhD, Nicholas Counsell, MSc, Janet Taylor, PhD, Cathy Burton, MBBChir, MA, MD FRCPath, Rachel Oakley, PhD, Joanna Williams, PhD, Sally F Barrington, Prof, MD PhD, Richard Byers, BSc, MSc, MBChB, PhD FRCPath, Timothy Illidge, MDPhD, John A. Radford, MD FMedSci

Blood (2020) 136 (Supplement 1): 18–19.

https://doi.org/10.1182/blood-2020-136318

Published: 2020

Journal Articles

Evidence That Activated Hedgehog Signaling Predicts for Poor Clinical Outcome in Acute Myeloid Leukemia

Veronica Campbell, BS, Eleni Tholouli, MD, PhD, M. Travis Quigley, MS, John Keilty, MS, Patrick Kelly, MD, Karen McGovern, PhD, Margaret Read, PhD, Jeffery L. Kutok, MD, PhD, Richard Byers, PhD, MBChB

Blood (2012) 120 (21): 1441.

https://doi.org/10.1182/blood.V120.21.1441.1441

Published: 2012

Journal Articles

Combined Targeting of the MET and FGF Receptor Tyrosine Kinases Induces Sustained AML Cell Death by Preventing Compensatory Upregulation of HGF in Response to MET Kinase Inhibition

Alex Kentsis, MD, PhD, Takaomi Sanda, MD, PhD, Casie Reed, BS, Scott J. Rodig, MD, PhD, Eleni Tholouli, PhD, MRCPath, Vu Ngo, PhD, Jeffery Lorne Kutok, MD, PhD, Suzanne E. Dahlberg, PhD, Lisa A Moreau, PhD, George Vande Woude, PhD, James Christensen, MD, Richard Byers, PhD, MBChB, FRCPath, Andrew L. Kung, MD, PhD, Louis M. Staudt, MD., Ph.D., Thomas Look, MD

Blood (2011) 118 (21): 1405.

https://doi.org/10.1182/blood.V118.21.1405.1405

Published: 2011

Journal Articles

Anti-HLA-DR Monoclonal Antibody Evokes a Novel Non-Apoptotic Cell Death Pathway In Acute Lymphoblastic Leukemia

Khimara Naidoo, Waleed Alduaij, Jamie Honeychurch, Eleanor Cheadle, Seema Alexander, Richard Byers, Vaskar Saha, Tim Illidge

Blood (2010) 116 (21): 3245.

https://doi.org/10.1182/blood.V116.21.3245.3245

Published: 2010

Journal Articles

Aberrant Expression of Hepatocyte Growth Factor Induces Autocrine MET Activation Providing a Novel Therapeutic Target In Acute Myeloid Leukemia.

Alex Kentsis, MD, PhD, Takaomi Sanda, MD, PhD, Vu Ngo, PhD, Scott J. Rodig, MD, PhD, Jeffery Kutok, MD, PhD, Eleni Tholouli, PhD, MRCPath, Richard Byers, PhD, MBChB, FRCPath, George Vande Woude, PhD, Andrew L. Kung, MD, PhD, Louis M. Staudt, MD, PhD, A. Thomas Look, MD

Blood (2010) 116 (21): 1042.

https://doi.org/10.1182/blood.V116.21.1042.1042

Published: 2010

Journal Articles

Blocks to paraffin get the CHOP, +R

Richard Byers

Blood (2008) 112 (8): 3006–3007.

https://doi.org/10.1182/blood-2008-07-166488

Published: 2008

Journal Articles

Quantum Dot Based Duplex In Situ Hybridisation for Gene Expression Profiling.

Eleni Tholouli, Dolores Di Vizio, Fionnuala O’Connell, Massimo Loda, David Twomey, Todd Golub, Richard Levenson, Judith A. Hoyland, John A.L. Yin, Richard Byers

Blood (2005) 106 (11): 3265.

https://doi.org/10.1182/blood.V106.11.3265.3265

Published: 2005

NARROW

Enhanced Outcome Prediction in Early Stage Classical Hodgkin Lymphoma Using Pre-Treatment Biomarkers and Interim PET (BioPET); A Sub-Analysis of the UK NCRI RAPID Trial

Evidence That Activated Hedgehog Signaling Predicts for Poor Clinical Outcome in Acute Myeloid Leukemia

Combined Targeting of the MET and FGF Receptor Tyrosine Kinases Induces Sustained AML Cell Death by Preventing Compensatory Upregulation of HGF in Response to MET Kinase Inhibition

Anti-HLA-DR Monoclonal Antibody Evokes a Novel Non-Apoptotic Cell Death Pathway In Acute Lymphoblastic Leukemia

Aberrant Expression of Hepatocyte Growth Factor Induces Autocrine MET Activation Providing a Novel Therapeutic Target In Acute Myeloid Leukemia.

Blocks to paraffin get the CHOP, +R

Quantum Dot Based Duplex In Situ Hybridisation for Gene Expression Profiling.

Email alerts

ASH Publications

American Society of Hematology

Enhanced Outcome Prediction in Early Stage Classical Hodgkin Lymphoma Using Pre-Treatment Biomarkers and Interim PET (BioPET); A Sub-Analysis of the UK NCRI RAPID Trial

Evidence That Activated Hedgehog Signaling Predicts for Poor Clinical Outcome in Acute Myeloid Leukemia

Combined Targeting of the MET and FGF Receptor Tyrosine Kinases Induces Sustained AML Cell Death by Preventing Compensatory Upregulation of HGF in Response to MET Kinase Inhibition

Anti-HLA-DR Monoclonal Antibody Evokes a Novel Non-Apoptotic Cell Death Pathway In Acute Lymphoblastic Leukemia

Aberrant Expression of Hepatocyte Growth Factor Induces Autocrine MET Activation Providing a Novel Therapeutic Target In Acute Myeloid Leukemia.

Blocks to paraffin get the CHOP, +R

Quantum Dot Based Duplex In Situ Hybridisation for Gene Expression Profiling.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only